Study Title: M22-574: Phase 3 ABBV-383 vs Standard Available Treatment in Subjects with RRMM with at Least 2 Prior Lines of Therapies
For more information about the trial above please contact the study team:Medical University of South CarolinaPrincipal Investigator, Green, Kimberly, at greekm@musc.edu.Study Coordinator, Schaefer, Matthew, at schaefma@musc.edu.Trial opened at the following institutions: Medical University of South Carolina